BACKGROUND: A standardized method for predicting unresectability in pancreatic cancer has not been defined. We propose a system using CT and endoscopic ultrasound (EUS) to assess patients for unresectable pancreatic cancers. METHODS: Radiologic and surgical data from 101 patients who underwent exploration/resection for pancreatic cancer were reviewed. Chi-squares were used to identify five factors significantly correlated with unresectability, which were incorporated into a scoring system (one point for each factor). RESULTS: The resectability rates were 84, 56, and 10% for patients with scores of 0, 1, and 2, respectively. All four patients with three risk factors for unresectability had unresectable tumors. The most accurate results were achieved in patients evaluated with both CT and EUS. DISCUSSION: This scoring system stratifies pancreatic cancer patients into three groups: (1) patients with a score of zero (likely to undergo successful resection), (2) patients with a score of one (likely to benefit from laparoscopic staging prior to attempting resection), and (3) patients with a score of two or higher (low probability of successful resection, who may be better served by neoadjuvant therapy).
BACKGROUND: A standardized method for predicting unresectability in pancreatic cancer has not been defined. We propose a system using CT and endoscopic ultrasound (EUS) to assess patients for unresectable pancreatic cancers. METHODS: Radiologic and surgical data from 101 patients who underwent exploration/resection for pancreatic cancer were reviewed. Chi-squares were used to identify five factors significantly correlated with unresectability, which were incorporated into a scoring system (one point for each factor). RESULTS: The resectability rates were 84, 56, and 10% for patients with scores of 0, 1, and 2, respectively. All four patients with three risk factors for unresectability had unresectable tumors. The most accurate results were achieved in patients evaluated with both CT and EUS. DISCUSSION: This scoring system stratifies pancreatic cancerpatients into three groups: (1) patients with a score of zero (likely to undergo successful resection), (2) patients with a score of one (likely to benefit from laparoscopic staging prior to attempting resection), and (3) patients with a score of two or higher (low probability of successful resection, who may be better served by neoadjuvant therapy).
Authors: Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun Journal: CA Cancer J Clin Date: 2005 Jan-Feb Impact factor: 508.702
Authors: Carlos Valls; Eduard Andía; Anna Sanchez; Juan Fabregat; Oscar Pozuelo; Juan Carlos Quintero; Teresa Serrano; Francisco Garcia-Borobia; Rosa Jorba Journal: AJR Am J Roentgenol Date: 2002-04 Impact factor: 3.959
Authors: C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt Journal: Ann Surg Date: 1995-06 Impact factor: 12.969
Authors: G M Fuhrman; C Charnsangavej; J L Abbruzzese; K R Cleary; R G Martin; C J Fenoglio; D B Evans Journal: Am J Surg Date: 1994-01 Impact factor: 2.565
Authors: John DeWitt; Benedict Devereaux; Melissa Chriswell; Kathleen McGreevy; Thomas Howard; Thomas F Imperiale; Donato Ciaccia; Kathleen A Lane; Dean Maglinte; Kenyon Kopecky; Julia LeBlanc; Lee McHenry; James Madura; Alex Aisen; Harvey Cramer; Oscar Cummings; Stuart Sherman Journal: Ann Intern Med Date: 2004-11-16 Impact factor: 25.391
Authors: Philip Bao; Douglas Potter; David P Eisenberg; Diana Lenzner; Herbert J Zeh; Kenneth Kw Lee Iii; Steven J Hughes; Michael K Sanders; Jennifer L Young; A James Moser Journal: HPB (Oxford) Date: 2009-11 Impact factor: 3.647
Authors: Philip Q Bao; J Chad Johnson; Elizabeth H Lindsey; David A Schwartz; Ron C Arildsen; Ewa Grzeszczak; Alexander A Parikh; Nipun B Merchant Journal: J Gastrointest Surg Date: 2007-10-23 Impact factor: 3.452
Authors: C K Enestvedt; S C Mayo; B S Diggs; M Mori; D A Austin; D K Shipley; B C Sheppard; K G Billingsley Journal: J Gastrointest Surg Date: 2008-05-10 Impact factor: 3.452
Authors: Robert C Moesinger; Jan W Davis; Britani Hill; W Cory Johnston; Carl Gray; Harold Johnson; Leslye Ingersoll; Gary Whipple; Mark Reilly; Robert Harris; Vincent Hansen Journal: Int J Surg Oncol Date: 2011-12-19
Authors: K Gerken; K J Roberts; B Reichert; R P Sutcliffe; F Marcon; S K Kamarajah; A Kaltenborn; T Becker; N G Heits; D F Mirza; J Klempnauer; H Schrem Journal: BJS Open Date: 2018-06-08